文献速递母胎医学产科

胎儿心肌病的临床表现、遗传病因与结局:两个时期的比较

Clinical presentation, genetic etiology and outcome associated with fetal cardiomyopathy: comparison of two eras.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

该回顾性研究纳入加拿大阿尔伯塔省2003–2019年38例胎儿心肌病病例,比较早期(2003–2012)与近期(2013–2019)的遗传诊断率及临床结局。近期组确认或高度怀疑遗传病因的比例显著高于早期组(76% vs 38%,P=0.04),但新生儿存活率差异无统计学意义(69% vs 45%,P=0.26)。

要点

  • 近期胎儿心肌病病例中确认或高度怀疑遗传病因的比例显著高于早期(76% vs 38%,P=0.04)。
  • 排除终止妊娠及计划姑息治疗病例后,近期组新生儿存活率69%(11/16)高于早期组45%(5/11),但差异无统计学意义(P=0.26)。
  • 38例中39%合并结构性心脏病,24%合并心律失常,29%初诊时已有水肿。

核心结论

  • 近期胎儿心肌病病例中确认或高度怀疑遗传病因的比例较早期显著升高。
  • 现代围产期管理策略可能对胎儿心肌病的新生儿存活率无显著影响,但需更大样本研究验证。

研究设计与样本

  • 回顾性队列研究,纳入加拿大阿尔伯塔省2003–2019年诊断的38例胎儿心肌病病例。
  • 排除继发于心脏外病理及母体状况的病例,比较早期(2003–2012)与近期(2013–2019)两个时期。

主要发现

  • 诊断时中位孕周22.8周(范围13.4–37.4周)。
  • 39%(15/38)合并结构性心脏病,24%(9/38)合并心律失常。
  • 29%(11/38)初诊时有水肿,另有18%(7/38)在孕晚期发生水肿。
  • 26%(10/38)终止妊娠,24%(9/38)宫内死亡;活产儿中新生儿死亡16%(3/19),晚期死亡21%(4/19),63%(12/19)末次随访存活。
  • 确认遗传病因39%(15/38),高度怀疑24%(9/38);近期组确认或高度怀疑遗传病因比例76%(19/25)显著高于早期组38%(5/13)(P=0.04)。

关键数值与推荐

  • 近期组与早期组新生儿存活率分别为69%(11/16)与45%(5/11),差异无统计学意义(P=0.26)。
  • 近期组确认或高度怀疑遗传病因比例76%(19/25)显著高于早期组38%(5/13)(P=0.04)。

临床怎么用

  • 对胎儿心肌病应重视遗传学评估,尤其近期病例中遗传病因检出率较高。
  • 围产期管理策略的改进对新生儿存活率的提升尚不明确,需个体化评估。

局限性

  • 样本量较小(38例),可能不足以检出新生儿存活率的显著差异。
  • 回顾性设计,存在选择偏倚和信息偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the rate and type of genetic diagnosis and clinical outcome of cases of fetal cardiomyopathy (CM) during two eras, in order to examine the impact of advanced genetic testing and improved perinatal management strategies. METHODS: All diagnoses of fetal CM in Alberta, Canada, encountered between 2003 and 2019, were reviewed retrospectively. Genetic, cardiac and non-cardiac diagnoses and clinical outcome were documented. Cases with CM secondary to extracardiac pathology and maternal conditions were excluded. Cases diagnosed in the earlier era of the study period (2003-2012) were compared with those diagnosed in the later era (2013-2019). RESULTS: Thirty-eight cases of fetal CM met the inclusion criteria. Median gestational age (GA) at diagnosis was 22.8 (range, 13.4-37.4) weeks. Associated structural heart disease was present in 39% (15/38) of cases and 24% (9/38) had arrhythmia. Hydrops was identified in 29% (11/38) of cases at presentation, and a further 18% (7/38) developed hydrops later in gestation. Twenty-six percent (10/38) of cases underwent termination of pregnancy and 24% (9/38) had intrauterine death. Of liveborn cases, neonatal death occurred in 16% (3/19), late death occurred in 21% (4/19) and 63% (12/19) were alive at the last follow-up. Excluding cases that had termination of pregnancy and those with a liveborn infant who received planned palliative care, the rate of neonatal survival was higher in the later compared with the earlier era (69% (11/16) vs 45% (5/11)), although the difference was not statistically significant (P = 0.26). A genetic etiology was confirmed in 39% (15/38) of cases and strongly suspected in 24% (9/38). A significantly higher proportion of cases had a confirmed or strongly suspected genetic etiology in the later era compared with in the earlier era (76% (19/25) vs 38% (5/13); P = 0.04). CONCLUSIONS: In the recent era, a higher proportion of fetal CM cases had a confirmed or strongly suspected genetic etiology than reported previously. Based on comparison with older series, modern perinatal management strategies may not have a significant impact on neonatal survival in cases of fetal CM; however, a larger study would be better powered to detect more subtle differences. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Trakmulkichkarn T, Ghadiry-Tavi R, Fruitman D, et al. Clinical presentation, genetic etiology and outcome associated with fetal cardiomyopathy: comparison of two eras. Ultrasound Obstet Gynecol. 2022. PMID: 34159662. doi:10.1002/uog.23713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。